114 related articles for article (PubMed ID: 3071448)
1. Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.
Weinstein MP
Diagn Microbiol Infect Dis; 1988 Dec; 11(4):195-200. PubMed ID: 3071448
[TBL] [Abstract][Full Text] [Related]
2. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
3. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485
[TBL] [Abstract][Full Text] [Related]
4. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.
Aldridge KE; Henderberg A; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-6S. PubMed ID: 2507219
[TBL] [Abstract][Full Text] [Related]
5. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
King A; Phillips I
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
Qadri SM; Lee GC; Ellis ME
Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
Floyd-Reising SA; Kelley SG; Hindler JA; Young LS
Diagn Microbiol Infect Dis; 1987 Apr; 6(4):301-6. PubMed ID: 3472704
[TBL] [Abstract][Full Text] [Related]
8. In-vitro assessment of lomefloxacin (SC-47111)--a new quinolone derivative.
Finch R; Martin J; Pilkington R
J Antimicrob Chemother; 1988 Dec; 22(6):881-4. PubMed ID: 3243735
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus.
Kropec A; Daschner F
Chemotherapy; 1989; 35(5):360-2. PubMed ID: 2507235
[TBL] [Abstract][Full Text] [Related]
10. Activity of ciprofloxacin against resistant clinical isolates.
Kelley SG; Bertram MA; Young LS
J Antimicrob Chemother; 1986 Mar; 17(3):281-6. PubMed ID: 2939048
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.
Chin NX; Novelli A; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):656-62. PubMed ID: 3164987
[TBL] [Abstract][Full Text] [Related]
12. In vitro antimicrobial activity and postantibiotic effect of lomefloxacin, a new difluoroquinolone.
Molinari G; Bandelloni R; Paglia P; Debbia E; Schito GC
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):53S-56S. PubMed ID: 2791499
[TBL] [Abstract][Full Text] [Related]
13. Lomefloxacin activity against 2,813 clinical isolates: a collaborative study at three medical centers in Brazil.
Magalhaes M; Trabulsi LR; Montelli AC
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):35S-39S. PubMed ID: 2791496
[TBL] [Abstract][Full Text] [Related]
14. Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
Verbist L
J Antimicrob Chemother; 1987 Sep; 20(3):363-72. PubMed ID: 3119552
[TBL] [Abstract][Full Text] [Related]
15. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
16. Laboratory assessment of lomefloxacin (SC-47111) in comparison with norfloxacin.
Edwards R; Kanematsu M; Greenwood D
J Antimicrob Chemother; 1988 Dec; 22(6):885-90. PubMed ID: 3243736
[TBL] [Abstract][Full Text] [Related]
17. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of lomefloxacin against multiply resistant Pseudomonas aeruginosa, Enterobacter cloacae, and Staphylococcus epidermidis.
DiVincenzo CA; Shatzer KL; Venezio FR
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):13S-16S. PubMed ID: 2507220
[TBL] [Abstract][Full Text] [Related]
19. The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
Neu HC
J Antimicrob Chemother; 1985 Jul; 16(1):43-8. PubMed ID: 3862659
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of lomefloxacin, a new difluoroquinolone.
Clarke AM; Zemcov SJ
Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):164-8. PubMed ID: 2498101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
